top of page

OIG's Latest Medicaid Managed Care Report Sends a Clear Message: Provider Directory Accuracy Is a Compliance Issue

  • Writer: Jessica Zeff
    Jessica Zeff
  • Jul 31
  • 2 min read

The Office of Inspector General recently released a report examining maternal health provider directories within Medicaid managed care plans. The findings should get the attention of every Medicaid managed care organization, not because they are surprising, but because they reinforce a trend we have been watching for several years: data accuracy is becoming a core compliance responsibility.


According to the report, approximately one-quarter of maternal health providers listed in plan network files reported they were not actually participating providers. More than one-quarter lacked accurate phone numbers, and nearly half of the providers included in plan network submissions were not reflected in the public-facing provider directories members rely on to find care.


At first glance, this may seem like an operational challenge for provider network teams. I would argue it is much more than that.


When Data Becomes a Compliance Risk


Managed care organizations routinely attest to the adequacy of their provider networks. States use provider network data to determine whether plans are meeting contractual and regulatory requirements related to access to care.


If the underlying data is inaccurate, then the organization's assessment of network adequacy may also be inaccurate.


That creates risk in several areas:


  • Regulatory oversight and state audits

  • Contractual compliance with Medicaid agencies

  • Member complaints and grievances

  • Access-to-care investigations

  • Quality and health equity initiatives

  • Potential allegations that network adequacy representations were misleading


The OIG has consistently identified network accuracy and so-called "ghost networks" as areas of concern across both Medicaid managed care and Medicare Advantage.


Recent guidance and reports demonstrate a growing focus on whether plans can substantiate the accuracy of the information they provide to regulators and beneficiaries.


Compliance Should Have a Seat at the Table


Historically, provider directory maintenance has been viewed as an operational function. However, the compliance implications now warrant greater oversight.


Compliance leaders should be asking:


  • How often are provider directories validated?

  • Are discrepancies tracked and trended?

  • Do we independently verify provider participation status?

  • How do we monitor member complaints related to inaccurate directory information?

  • Are network adequacy submissions subject to compliance review?

  • Can we demonstrate the reliability of the data used in regulatory reporting?


These questions are no different from the questions we ask about claims data, encounter submissions, or quality reporting.


The Bigger Picture: Access to Care


What makes this report particularly important is that it focuses on maternal health care.


Medicaid finances more than 40 percent of births in the United States, and most pregnant Medicaid beneficiaries receive coverage through managed care organizations. When provider information is inaccurate, the impact extends beyond administrative inconvenience. It can delay access to prenatal care, create barriers to specialist services, and contribute to poorer health outcomes.


For compliance professionals, this is an important reminder that data integrity is not just about avoiding audit findings. It is about ensuring that members can access the care they need.


The Compliance Takeaway


The OIG's report should prompt Medicaid managed care organizations to rethink how provider directory accuracy is governed.


Provider directories are no longer simply member-facing tools. They are increasingly being viewed as evidence of network adequacy, access to care, and organizational accountability.


The organizations that treat provider data as a compliance asset rather than an operational byproduct will be better positioned for audits, regulatory scrutiny, and—most importantly—member access to care.


Comments


bottom of page